MJP Associates Inc. ADV Raises Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

MJP Associates Inc. ADV increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 29.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,054 shares of the medical equipment provider’s stock after acquiring an additional 240 shares during the period. MJP Associates Inc. ADV’s holdings in Intuitive Surgical were worth $550,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in ISRG. Atala Financial Inc purchased a new position in Intuitive Surgical in the 4th quarter worth $25,000. Berbice Capital Management LLC purchased a new position in Intuitive Surgical in the 4th quarter worth $26,000. Parvin Asset Management LLC purchased a new position in shares of Intuitive Surgical during the 4th quarter valued at about $26,000. BankPlus Trust Department purchased a new position in shares of Intuitive Surgical during the 4th quarter valued at about $28,000. Finally, Hurley Capital LLC purchased a new position in shares of Intuitive Surgical during the 4th quarter valued at about $28,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Myriam Curet sold 408 shares of the stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total value of $240,618.00. Following the completion of the transaction, the executive vice president now directly owns 353 shares of the company’s stock, valued at approximately $208,181.75. This trade represents a 53.61% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Jami K. Nachtsheim sold 2,400 shares of the firm’s stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the transaction, the director now directly owns 6,371 shares of the company’s stock, valued at approximately $3,312,920. This trade represents a 27.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 33,044 shares of company stock valued at $17,070,433 over the last ninety days. Corporate insiders own 0.70% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on ISRG. Citigroup lifted their price objective on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Truist Financial dropped their target price on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating on the stock in a research report on Wednesday, April 23rd. Royal Bank of Canada dropped their target price on Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 23rd. Bernstein Bank raised their target price on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research report on Monday, January 27th. Finally, Piper Sandler dropped their target price on Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 23rd. Five equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $598.95.

Check Out Our Latest Report on ISRG

Intuitive Surgical Trading Down 0.3%

Shares of ISRG stock opened at $536.55 on Monday. Intuitive Surgical, Inc. has a 12 month low of $379.67 and a 12 month high of $616.00. The company has a market cap of $192.31 billion, a P/E ratio of 83.71, a PEG ratio of 5.85 and a beta of 1.70. The firm has a fifty day moving average price of $500.93 and a 200 day moving average price of $535.03.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last announced its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The business had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. During the same quarter in the prior year, the firm earned $1.50 earnings per share. On average, equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Company Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Featured Articles

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.